NVS logo

Novartis AG (NVS) Revenue

Annual revenue:

$50.29B+$4.85B(+10.67%)
December 31, 2024

Summary

  • As of today (August 22, 2025), NVS annual revenue is $50.29 billion, with the most recent change of +$4.85 billion (+10.67%) on December 31, 2024.
  • During the last 3 years, NVS annual revenue has fallen by -$1.34 billion (-2.59%).
  • NVS annual revenue is now -13.23% below its all-time high of $57.96 billion, reached on December 31, 2011.

Performance

NVS Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSincome statement metrics

Quarterly revenue:

$14.28B+$1.05B(+7.91%)
June 30, 2025

Summary

  • As of today (August 22, 2025), NVS quarterly revenue is $14.28 billion, with the most recent change of +$1.05 billion (+7.91%) on June 30, 2025.
  • Over the past year, NVS quarterly revenue has increased by +$1.77 billion (+14.13%).
  • NVS quarterly revenue is now -11.16% below its all-time high of $16.07 billion, reached on June 30, 2011.

Performance

NVS Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSincome statement metrics

TTM revenue:

$53.40B+$1.77B(+3.42%)
June 30, 2025

Summary

  • As of today (August 22, 2025), NVS TTM revenue is $53.40 billion, with the most recent change of +$1.77 billion (+3.42%) on June 30, 2025.
  • Over the past year, NVS TTM revenue has increased by +$5.85 billion (+12.30%).
  • NVS TTM revenue is now -13.99% below its all-time high of $62.08 billion, reached on September 30, 2011.

Performance

NVS TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSincome statement metrics

NVS Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.7%+14.1%+12.3%
3 y3 years-2.6%+11.7%+3.5%
5 y5 years+5.9%+25.9%+10.8%

NVS Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-2.6%+19.1%at high+36.1%at high+23.3%
5 y5-year-2.6%+19.1%at high+36.1%at high+23.3%
alltimeall time-13.2%+165.0%-11.2%+233.8%-14.0%+837.3%

NVS Revenue History

DateAnnualQuarterlyTTM
Jun 2025
-
$14.28B(+7.9%)
$53.40B(+3.4%)
Mar 2025
-
$13.23B(+1.3%)
$51.63B(+2.8%)
Dec 2024
$50.29B(+10.7%)
$13.06B(+1.8%)
$50.22B(+3.4%)
Sep 2024
-
$12.82B(+2.5%)
$48.59B(+2.2%)
Jun 2024
-
$12.51B(+5.8%)
$47.55B(+2.3%)
Mar 2024
-
$11.83B(+3.6%)
$46.46B(+2.2%)
Dec 2023
$45.44B(+7.7%)
$11.42B(-3.0%)
$45.46B(+1.9%)
Sep 2023
-
$11.78B(+3.1%)
$44.61B(+3.0%)
Jun 2023
-
$11.43B(+5.6%)
$43.32B(-3.0%)
Mar 2023
-
$10.82B(+2.3%)
$44.67B(-3.7%)
Dec 2022
$42.21B(-18.2%)
$10.58B(+0.8%)
$46.38B(-5.4%)
Sep 2022
-
$10.49B(-17.9%)
$49.03B(-4.9%)
Jun 2022
-
$12.78B(+2.0%)
$51.57B(-0.3%)
Mar 2022
-
$12.53B(-5.3%)
$51.75B(+0.2%)
Dec 2021
$51.63B(+6.1%)
$13.23B(+1.5%)
$51.63B(+0.9%)
Sep 2021
-
$13.03B(+0.6%)
$51.17B(+1.5%)
Jun 2021
-
$12.96B(+4.4%)
$50.40B(+3.3%)
Mar 2021
-
$12.41B(-2.8%)
$48.79B(+0.3%)
Dec 2020
$48.66B(+2.4%)
$12.77B(+4.2%)
$48.66B(+0.8%)
Sep 2020
-
$12.26B(+8.0%)
$48.29B(+0.2%)
Jun 2020
-
$11.35B(-7.6%)
$48.20B(-0.9%)
Mar 2020
-
$12.28B(-1.0%)
$48.62B(+2.4%)
Dec 2019
$47.50B(+5.9%)
$12.40B(+1.9%)
$47.50B(+1.9%)
Sep 2019
-
$12.17B(+3.5%)
$46.60B(+2.5%)
Jun 2019
-
$11.76B(+5.4%)
$45.47B(+0.9%)
Mar 2019
-
$11.16B(-3.0%)
$45.06B(+0.5%)
Dec 2018
$44.83B(-8.7%)
$11.50B(+4.1%)
$44.83B(-3.1%)
Sep 2018
-
$11.04B(-2.8%)
$46.25B(-2.9%)
Jun 2018
-
$11.36B(+3.9%)
$47.62B(-1.8%)
Mar 2018
-
$10.93B(-15.4%)
$48.50B(-1.2%)
Dec 2017
$49.11B(+1.2%)
$12.91B(+4.0%)
$49.11B(+1.2%)
Sep 2017
-
$12.41B(+1.4%)
$48.52B(+0.6%)
Jun 2017
-
$12.24B(+6.1%)
$48.23B(-0.5%)
Mar 2017
-
$11.54B(-6.4%)
$48.46B(-0.1%)
Dec 2016
$48.52B(-1.9%)
$12.32B(+1.6%)
$48.52B(-0.4%)
Sep 2016
-
$12.13B(-2.8%)
$48.72B(-0.3%)
Jun 2016
-
$12.47B(+7.5%)
$48.85B(-0.5%)
Mar 2016
-
$11.60B(-7.3%)
$49.08B(-0.7%)
Dec 2015
$49.44B(-5.7%)
$12.52B(+2.1%)
$49.44B(-1.2%)
Sep 2015
-
$12.27B(-3.4%)
$50.05B(-1.5%)
Jun 2015
-
$12.69B(+6.1%)
$50.83B(-1.9%)
Mar 2015
-
$11.96B(-8.9%)
$51.80B(-4.5%)
Dec 2014
$52.42B(+0.6%)
$13.13B(+0.6%)
$54.23B(-0.6%)
Sep 2014
-
$13.05B(-4.5%)
$54.54B(+0.5%)
Jun 2014
-
$13.67B(-5.0%)
$54.24B(+1.0%)
Mar 2014
-
$14.38B(+7.0%)
$53.71B(+0.6%)
Dec 2013
$52.09B(-8.1%)
$13.44B(+5.4%)
$53.41B(-2.5%)
Sep 2013
-
$12.75B(-2.9%)
$54.80B(-1.0%)
Jun 2013
-
$13.13B(-6.8%)
$55.34B(-0.9%)
Mar 2013
-
$14.09B(-5.0%)
$55.86B(+2.0%)
Dec 2012
$56.67B(-2.2%)
$14.83B(+11.5%)
$54.79B(+1.1%)
Sep 2012
-
$13.30B(-2.6%)
$54.17B(-4.8%)
Jun 2012
-
$13.65B(+4.8%)
$56.93B(-4.1%)
Mar 2012
-
$13.02B(-8.4%)
$59.35B(-3.0%)
DateAnnualQuarterlyTTM
Dec 2011
$57.96B(+15.4%)
$14.21B(-11.4%)
$61.22B(-1.4%)
Sep 2011
-
$16.05B(-0.2%)
$62.08B(+5.6%)
Jun 2011
-
$16.07B(+8.0%)
$58.81B(+9.0%)
Mar 2011
-
$14.88B(-1.3%)
$53.93B(+5.4%)
Dec 2010
$50.22B(+13.9%)
$15.08B(+18.0%)
$51.18B(+2.8%)
Sep 2010
-
$12.78B(+14.1%)
$49.79B(+3.7%)
Jun 2010
-
$11.19B(-7.7%)
$48.01B(+1.4%)
Mar 2010
-
$12.13B(-11.4%)
$47.37B(+5.4%)
Dec 2009
$44.10B(+6.4%)
$13.69B(+24.4%)
$44.95B(+8.7%)
Sep 2009
-
$11.00B(+4.2%)
$41.34B(+0.2%)
Jun 2009
-
$10.55B(+8.7%)
$41.27B(-0.5%)
Mar 2009
-
$9.71B(-3.6%)
$41.47B(+0.2%)
Dec 2008
$41.46B(+8.9%)
$10.08B(-7.8%)
$41.38B(+0.4%)
Sep 2008
-
$10.93B(+1.6%)
$41.24B(+3.3%)
Jun 2008
-
$10.76B(+11.8%)
$39.92B(+3.6%)
Mar 2008
-
$9.62B(-3.1%)
$38.54B(+0.3%)
Dec 2007
$38.07B(+10.7%)
$9.93B(+3.3%)
$38.42B(+1.4%)
Sep 2007
-
$9.61B(+2.6%)
$37.89B(+2.1%)
Jun 2007
-
$9.37B(-1.5%)
$37.10B(+2.7%)
Mar 2007
-
$9.51B(+1.2%)
$36.14B(+4.2%)
Dec 2006
$34.39B(+10.9%)
$9.40B(+6.5%)
$34.69B(+5.9%)
Sep 2006
-
$8.83B(+5.0%)
$32.74B(+1.3%)
Jun 2006
-
$8.41B(+4.3%)
$32.33B(+2.4%)
Mar 2006
-
$8.06B(+8.2%)
$31.57B(+1.6%)
Dec 2005
$31.00B(+10.4%)
$7.45B(-11.5%)
$31.06B(-1.5%)
Sep 2005
-
$8.41B(+10.0%)
$31.53B(+4.2%)
Jun 2005
-
$7.65B(+1.3%)
$30.25B(+2.3%)
Mar 2005
-
$7.55B(-4.6%)
$29.57B(+2.1%)
Dec 2004
$28.09B(+13.8%)
$7.91B(+11.0%)
$28.95B(+3.7%)
Sep 2004
-
$7.13B(+2.3%)
$27.92B(+3.4%)
Jun 2004
-
$6.97B(+0.6%)
$27.01B(+1.7%)
Mar 2004
-
$6.93B(+0.8%)
$26.55B(+3.2%)
Dec 2003
$24.68B(+18.5%)
$6.88B(+10.7%)
$25.72B(+5.4%)
Sep 2003
-
$6.22B(-4.6%)
$24.40B(+3.6%)
Jun 2003
-
$6.51B(+6.7%)
$23.56B(+5.9%)
Mar 2003
-
$6.10B(+9.6%)
$22.24B(+6.5%)
Dec 2002
$20.83B(+9.8%)
$5.57B(+3.6%)
$20.88B(+2.4%)
Sep 2002
-
$5.37B(+3.5%)
$20.38B(+2.6%)
Jun 2002
-
$5.19B(+9.5%)
$19.86B(+2.8%)
Mar 2002
-
$4.74B(-6.6%)
$19.32B(+1.8%)
Dec 2001
$18.97B(-10.5%)
$5.07B(+4.6%)
$18.98B(-6.1%)
Sep 2001
-
$4.85B(+4.4%)
$20.22B(-0.1%)
Jun 2001
-
$4.65B(+5.6%)
$20.25B(+1.9%)
Mar 2001
-
$4.40B(-30.3%)
$19.88B(-6.1%)
Dec 2000
$21.19B(-1.8%)
$6.31B(+29.4%)
$21.17B(+42.5%)
Sep 2000
-
$4.88B(+14.1%)
$14.86B(+48.9%)
Jun 2000
-
$4.28B(-24.9%)
$9.97B(+75.1%)
Mar 2000
-
$5.70B
$5.70B
Dec 1999
$21.59B(-1.3%)
-
-
Dec 1998
$21.88B(+1.8%)
-
-
Dec 1997
$21.49B(-26.7%)
-
-
Dec 1996
$29.32B(-3.6%)
-
-
Dec 1995
$30.43B(+9.7%)
-
-
Dec 1994
$27.75B(+8.6%)
-
-
Dec 1993
$25.54B
-
-

FAQ

  • What is Novartis AG annual revenue?
  • What is the all time high annual revenue for Novartis AG?
  • What is Novartis AG annual revenue year-on-year change?
  • What is Novartis AG quarterly revenue?
  • What is the all time high quarterly revenue for Novartis AG?
  • What is Novartis AG quarterly revenue year-on-year change?
  • What is Novartis AG TTM revenue?
  • What is the all time high TTM revenue for Novartis AG?
  • What is Novartis AG TTM revenue year-on-year change?

What is Novartis AG annual revenue?

The current annual revenue of NVS is $50.29B

What is the all time high annual revenue for Novartis AG?

Novartis AG all-time high annual revenue is $57.96B

What is Novartis AG annual revenue year-on-year change?

Over the past year, NVS annual revenue has changed by +$4.85B (+10.67%)

What is Novartis AG quarterly revenue?

The current quarterly revenue of NVS is $14.28B

What is the all time high quarterly revenue for Novartis AG?

Novartis AG all-time high quarterly revenue is $16.07B

What is Novartis AG quarterly revenue year-on-year change?

Over the past year, NVS quarterly revenue has changed by +$1.77B (+14.13%)

What is Novartis AG TTM revenue?

The current TTM revenue of NVS is $53.40B

What is the all time high TTM revenue for Novartis AG?

Novartis AG all-time high TTM revenue is $62.08B

What is Novartis AG TTM revenue year-on-year change?

Over the past year, NVS TTM revenue has changed by +$5.85B (+12.30%)
On this page